Hayes, now a part of symplr
  • Payer Solutions
    • Evidence Solutions
    • Services and Technology
  • About Hayes
    • Mission
    • Origins
    • Careers
    • Contact Us
  • Client Login
  • Publications
      • Evidence Analysis


      • Health Technology Assessments


      • Evolving Evidence Review

      • Precision Medicine


      • Clinical Utility Evaluation


      • Molecular Test Assessment


      • Precision Medicine Insights

      • Horizon Scanning


      • Emerging Technology Report

Select Page
  • Payer Solutions
    • Evidence Solutions
    • Services and Technology
  • About Hayes
    • Mission
    • Origins
    • Careers
    • Contact Us
  • Client Login
  • Publications
      • Evidence Analysis


      • Health Technology Assessments


      • Evolving Evidence Review

      • Precision Medicine


      • Clinical Utility Evaluation


      • Molecular Test Assessment


      • Precision Medicine Insights

      • Horizon Scanning


      • Emerging Technology Report

Telavancin (Vibativ®) for the Treatment of Adults with Complicated Skin and Skin Structure Infection (cSSSI)

by TractManager | Sep 15, 2009 | Emerging Technology Report

An intravenous antibiotic for complicated skin and skin structure infection caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.If you have a Hayes login, click here to view the full report on the Knowledge Center.

Total Facet Arthroplasty System® (TFAS®)

by TractManager | Sep 4, 2009 | Emerging Technology Report

A modular, pedicle-screw-based implant designed for facet joint replacement in patients with lumbar spinal stenosis and facet joint degeneration.   If you have a Hayes login, click here to view the full report on the Knowledge...

Recent Posts

  • Cologuard (Exact Sciences Corp.) for Colorectal Cancer Screening in Average-Risk Adults
  • Aortix Percutaneous Mechanical Circulatory Support Device
  • Zavegepant (Zavzpret) for Acute Treatment of Migraine
  • Omecamtiv Mecarbil for Heart Failure With Reduced Ejection Fraction (HFrEF)
  • Trofinetide (Daybue) for Rett Syndrome

Recent Comments

    Archives

    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • August 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
    • November 2013
    • October 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • June 2009
    • May 2009
    • March 2009
    • February 2009
    • November 2008
    • September 2008
    • July 2008
    • May 2008

    Categories

    • Clinical Utility Evaluation
    • Contract Management
    • COVID-Articles
    • COVID-News
    • Emerging Technology Report
    • Evolving Evidence Review
    • Health Technology Assessment
    • Molecular Test Assessment
    • News
    • Precision Medicine Insights
    • Precision Therapy Assessment
    • Publications
    • Strategic Sourcing

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
      • About Hayes
      • Careers

    • Payer Evidence Solutions
    • Services and Technology
    • Publications

    • Contact Us
    • 855-527-9669
    • accountservices@hayesinc.com
    • Follow
    • Follow
    • Follow

    Client Login

    Log In

    Copyright © 2021 Hayes, a symplr company | Privacy Policy

    This site uses cookies. By continuing to use this website, you agree to their use. For details, please review our Privacy Policy